Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
Cell plasma membrane proteins are considered as gatekeepers of the cell and play a major role in regulating various processes. Transport proteins constitute a subclass of cell plasma membrane proteins enabling the exchange of molecules and ions between the extracellular environment and the cytosol....
Main Authors: | Raf Van Campenhout, Serge Muyldermans, Mathieu Vinken, Nick Devoogdt, Timo W.M. De Groof |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/1/63 |
Similar Items
-
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01) -
Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
by: Ema Romão, et al.
Published: (2020-01-01) -
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
by: Yaozhong Hu, et al.
Published: (2017-11-01) -
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
by: Jing Zuo, et al.
Published: (2017-10-01) -
Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment
by: Golnaz Sadeghnezhad, et al.
Published: (2019-09-01)